Epitope analysis of myeloperoxidase-specific antineutrophil cytoplasmic autoantibodies (MPO-ANCA) in childhood onset Graves' disease treated with propylthiouracil

Clinical Nephrology

Volumn 63, Issue 6, 2005, Pages 437-445

  Fujieda, M ^a   Suzuki, K ^b   Sato, H ^c   Hattori, M ^d   Wada, N ^e   Tsuchiya, M ^f   Okamoto, N ^g   Murata, T ^g   Matsudaira, M ^h   Shimizu, M ⁱ   Ohta, K ⁱ   Naruse, K ^a   Sugihara, S ^j   Wakiguchi, H ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c CHIBA CHILDREN'S HOSPITAL   (Japan)

^d TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^e SHIZUOKA CHILDREN'S HOSPITAL   (Japan)

^f NIPPON MEDICAL SCHOOL HOSPITAL   (Japan)

^g OSAKA MEDICAL COLLEGE   (Japan)

^h NAGASAKI UNIVERSITY   (Japan)

ⁱ KANAZAWA UNIVERSITY   (Japan)

^j TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

more..

Author keywords

Antineutrophil cytoplasmic autoantibody; Epitope; Graves' disease; Myeloperoxidase; Propylthiouracil

Indexed keywords

CORTICOSTEROID; CREATININE; EPITOPE; IMMUNOSUPPRESSIVE AGENT; METHIONINE; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; POLYCLONAL ANTIBODY; PREDNISOLONE; PROPYLTHIOURACIL; THIAMAZOLE;

ADOLESCENT; ADULT; AMINO TERMINAL SEQUENCE; ARTICLE; BLOOD ANALYSIS; CARBOXY TERMINAL SEQUENCE; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; CLONAL VARIATION; CONTROLLED STUDY; DELETION MUTANT; DOWNSTREAM PROCESSING; ENZYME ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULONEPHRITIS; GRAVES DISEASE; HEAVY CHAIN; HUMAN; KIDNEY BIOPSY; LUNG HEMORRHAGE; MALE; NEPHRITIS; PATIENT MONITORING; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; RISK ASSESSMENT; SCHOOL CHILD; VASCULITIS;

EID: 21044437556     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CNP63437     Document Type: Article

References (25)

1. Aoki A, Suzuki H, Ohata T, Ohno S, Nagaoka S, Chiba J, Kanamaru T, Usuda Y 1995 A case of p-ANCA-positive necrotizing vasculitis associated with Graves' disease. Rheumatism (Ryeumachi) 35: 683-687 (in Japanese)
2. Chang L, Binos S, Savige J 1995 Epitope mapping of anti-proteinase 3 and anti-myeloperoxidase antibodies. Clin Exp Immunol 102: 112-119
3. Cohen P, Guillevin L, Baril L, Lhote F, Noel LH, Lesavre P 1995 Persistence of antineutrophil cytoplasmic antibodies (ANCA) in asymptomatic patients with systemic polyarteritis nodosa or Churg-Strauss syndrome: follow-up of 35 patients. Clin Exp Rheumatol 13: 193-198
4. Davies DJ, Moran JE, Niall JF 1982 Segmental necrotizing glomerulonephritis with antineutrophil antibody: possible arbovirus? Br Med J 285: 606-607
5. D'Cruz D, Chesser AMS, Lightowler C, Coiner M, Hurst MJ, Baker LRI, Raine AEG 1995 Antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis associated with anti-thyroid drug treatment. Br J Rheumatol 34: 1090-1091
6. Falk RJ, Becker M, Terrell R, Jennette JC 1992 Antimyeloperoxidase autoantibodies react with native but not denatured myeloperoxidase. Clin Exp Immunol 89: 274-278
7. Freire BA, Paula ID, Paula F, Kallenberg CGM, Limburg PC, Queluz TT 2001 Absence of cross-reactivity to myeloperoxidase of anti-thyroid microsomal antibodies in patients with autoimmume thyroid disease. Am J Med Sci 321: 109-112
8. Fujieda M, Hattori M, Kurayama H, Koitabashi Y, and members and coworkers of the Japanese Society for Pediatric Nephrology 2002 Clinical features and outcomes in children with antineutrophil cytoplasmic autoantibody-positive glomerulonephritis associated with propylthiouracil treatment. J Am Soc Nephrol 13: 437-445
9. Fujii A, Tomizawa K, Arimura Y, Nagasawa T, Ohashi Y, Hiyama T, Mizuno S, Suzuki K 2000 Epitope analysis of myeloperoxidase- (MPO) specific anti-neutrophil cytoplasmic autoantibodies (ANCA) in MPO-ANCA-associated glomerulonephritis. Clin Nephrol 53:242-252
10. Guo J, Yan X-M, McLachlan SM, Rapoport B 2001 Search for the autoantibody immunodominant region on thyroid peroxidase: epitope footprinting with a human monoclonal autoantibody locates a facet on the native antigen containing a highly conformational epitope. J Immunol 166: 1327-1333
11. Hashinaka K, Nishio C, Hur SJ, Sakiyama F, Tsunasawa S, Yamada M 1988 Multiple species of myeloperoxidase messenger RNAs produced by alternative splicing and differential polyadenylation. Biochemistry 27: 5906-5914
12. Hirooka Y, Hasegawa M, Ohga S, Kimura M, Mitsuya T 1992 Fundamental and clinical evaluation of the measurement of autoantibodies to thyroglobulin and to thyroid peroxidase. Clin Endocrinol 40: 547-554 (in Japanese)
13. Jayne DR, Gaskin G Pusey CD, Lockwood CM 1995 ANCA and predicting relapse in systemic vasculitis. Q J Med 88: 127-133
14. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, Hoffman GS, Hunder GG, Kallenberg CGM, McCluskey RT, Sinico RA, Rees AJ, van ES LA, Waldherr R, Wiik A 1994 Nomenclature of systemic vasculitides: proposal of an international consensus conference. Arthritis Rheum 37: 187-192
15. Kawachi Y, Nukaga H, Hoshino M, Iwata M, Otsuka F 1995 ANCA-associated vasculitis and lupus-like syndrome caused by methimazole. Clin Exp Dermatol 20: 345-347
16. 14C] propylthiouracil in human polymorphonuclear leukocytes. Biochem Pharmacol 28: 2289-2296
17. Lee E, Hirouchi M, Hosokawa M, Sayo H, Kohno M, Kariya K 1988 Inactivation of peroxidase of rat bone marrow by repeated administration of propylthiouracil is accompanied by a change of the heme structure. Biochem Pharmacol 37: 2152-2153
18. Nagasawa T, Arimura Y, Yoshida M, Hiromura K, Naruse T, Nishiki N, Tokuda K 1995 Fundamental and clinical evaluation of MPO-ANCA ELISA kit (NISSHO). Rinkenkiki Shinyaku 18: 127-135 (in Japanese)
19. Nagasawa T, Arimura Y, Yoshida M, Umekage M, Mitsuhida N 1992 C-ANCA investigated by ELISA kit (BioCarb) and its clinical usefulness in Wegener's granulomatosis. Rinkenkiki Shinyaku 15: 503-510 (in Japanese)
20. Otani I, Ishida-Okawara A, Yamagoe S, Miyoshi-Koshio T, Arimura Y, Nagasawa T, Mizuno S, Suzuki K 1997 Myeloperoxidase fragments reacting with serum from a patient with myeloperoxidase anti-neutrophil cytoplasmic antibody-positive glomerulonephritis. J Infect Chemother 3: 164-169
21. Rapoport B, McLachlan 2001 Thyroid autoimmunity. J Clin Invest 108: 1253-1259
22. Sato H, Hattori M, Fujieda M, Sugihara S, Inomata H, Hashi M, Miyamoto S 2000 High prevalence of antineutrophil cytoplasmic antibody positivity in childhood onset Graves' disease treated with propylthiouracil. J Clin Endocrinol Metab 85: 4270-4273
23. Savige J, Davies D, Falk RJ, Jennette JC, Wiik A 2000 Antineutrophil cytoplasmic antibodies and associated disease: a review of the clinical and laboratory features. Kidney Int 57: 846-862
24. Tomizawa K, Mine E, Fujii A, Ohasi Y, Yamagoe S, Hashimoto Y, Ishida-Okawara A, Ito M, Tanokura M, Yamamoto T, Arimura Y, Nagasawa T, Mizuno S, Suzuki K 1998 A panel set for epitope analysis of myeloperoxidase- (MPO) specific antineutrophil cytoplasmic antibody (MPO-ANCA) using recombinant hexamer histidine-tagged MPO deletion mutants. J Clin Immunol 18: 142-152
25. Wiik A 1989 Delineation of a standard procedure for indirect immunofluorescence detection of ANCA. APMIS Suppl 6: 12-13